Universidad Peruana Cayetano Heredia

Anti–MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon

Mostrar el registro sencillo del ítem

dc.contributor.author Rosas-Aguirre, A.
dc.contributor.author Patra, K.P.
dc.contributor.author Calderón Sánchez, Maritza Mercedes
dc.contributor.author Torres Fajardo, Katherine Jessica
dc.contributor.author Gamboa Vilela, Dionicia Baziliza
dc.contributor.author Arocutipa, E.
dc.contributor.author Málaga, E.
dc.contributor.author Garro, K.
dc.contributor.author Fernández, C.
dc.contributor.author Trompeter, G.
dc.contributor.author Alnasser, Y.
dc.contributor.author Llanos Cuentas, Elmer Alejandro
dc.contributor.author Gilman, Robert Hugh
dc.contributor.author Vinetz, Joseph Michael
dc.date.accessioned 2020-12-14T16:10:08Z
dc.date.available 2020-12-14T16:10:08Z
dc.date.issued 2020
dc.identifier.uri https://hdl.handle.net/20.500.12866/8786
dc.description.abstract BACKGROUND. Serological tools for the accurate detection of recent malaria exposure are needed to guide and monitor malaria control efforts. IgG responses against Plasmodium vivax and P. falciparum merozoite surface protein-10 (MSP10) were measured as a potential way to identify recent malaria exposure in the Peruvian Amazon. METHODS. A field-based study included 470 participants in a longitudinal cohort who completed a comprehensive evaluation: light microscopy and PCR on enrollment, at least 1 monthly follow-up by light microscopy, a second PCR, and serum and dried blood spots for serological analysis at the end of the follow-up. IgG titers against novel mammalian cell–produced recombinant PvMSP10 and PfMSP10 were determined by ELISA. RESULTS. During the follow-up period, 205 participants were infected, including 171 with P. vivax, 26 with P. falciparum, 6 with infections by both species but at different times, and 2 with mixed infections. Exposure to P. vivax was more accurately identified when serological responses to PvMSP10 were obtained from serum (sensitivity, 58.1%; specificity, 81.8%; AUC: 0.76) than from dried blood spots (sensitivity, 35.2; specificity, 83.5%; AUC: 0.64) (PAUC < 0.001). Sensitivity was highest (serum, 82.9%; dried blood spot, 45.7%) with confirmed P. vivax infections occurring 7–30 days before sample collection; sensitivity decreased significantly in relation to time since last documented infection. PvMSP10 serological data did not show evidence of interspecies cross-reactivity. Anti-PfMSP10 responses poorly discriminated between P. falciparum–exposed and nonexposed individuals (AUC = 0.59; P > 0.05). CONCLUSION. Anti-PvMSP10 IgG indicates recent exposure to P. vivax at the population level in the Amazon region. Serum, not dried blood spots, should be used for such serological tests. FUNDING. Cooperative agreement U19AI089681 from the United States Public Health Service, NIH/ National Institute of Allergy and Infectious Diseases, as the Amazonian International Center of Excellence in Malaria Research. en_US
dc.language.iso eng
dc.publisher American Society for Clinical Investigation
dc.relation.ispartofseries JCI Insight
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Anti–MSP-10 IgG en_US
dc.subject Plasmodium vivax en_US
dc.subject Infection en_US
dc.subject Peruvian Amazon en_US
dc.title Anti–MSP-10 IgG indicates recent exposure to Plasmodium vivax infection in the Peruvian Amazon en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1172/jci.insight.130769
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00
dc.relation.issn 2379-3708


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas